Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Researchers at RCT discover novel compounds for degenerative bone disorders

Dec. 6, 2000

Recent patent covers GelTex's newest polymer bile acid sequestrants

Dec. 5, 2000

Androgen glycosides improve oral absorption of active ingredient

Dec. 5, 2000

Thrombopoietin mimics emerge from SmithKline Beecham R&D

Dec. 5, 2000

AxyS and Merck extend osteoporosis collaboration once again

Dec. 5, 2000

Effects of NK-104 on lipid profiles, atherosclerosis in WHHL rabbits

Dec. 5, 2000

Recombinant urate oxidase is a safe and effective uricolytic agent in hematological malignancies

Dec. 4, 2000

Novel series of tricyclic osteogenesis promoters patented by Taisho

Dec. 4, 2000

BioStratum and Shire collaborate on XR formulation of Pyridorin

Dec. 4, 2000

EMEA recommends approval of Reductil for management of obesity

Dec. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...